Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Clinical trial NCT03080883 · COMPLETED

Trial details

NCT number: NCT03080883
Sponsor: Academic and Community Cancer Research United
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Vein Thrombosis Deep Vein Thrombosis Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm Pulmonary Embolism Splanchnic Vein Thrombosis

Start date: 2017-07-14
Primary completion: 2022-06-07
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.